Evidence map›Paper›PMID 24531378›Full record

ArticleNature medicine2014

Rejuvenation of the muscle stem cell population restores strength to injured aged muscles.

Benjamin D Cosgrove, Penney M Gilbert, Ermelinda Porpiglia, Foteini Mourkioti, Steven P Lee, Stephane Y Corbel, Michael E Llewellyn, Scott L Delp, Helen M Blau

Open access · greenAbstract read
In one paragraph

Article in Nature medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 406 papers.

0numbers the graph read from it
0cells of the map it votes in
406citing papers in PubMed
29.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

406 citing papers in PubMed, 653 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Youthfulness of marrow AdipoqBone research · 2026
    Article
  11. Review
  12. Alterations of actin in aging.Journal of cell science · 2026
    Review
  13. Review
  14. 15-PGDH inhibition promotes muscle repair and strength recovery during GLP-1 receptor agonist-induced weight loss.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review

346 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Benjamin D CosgroveBaxter Laboratory for Stem Cell Biology, Department of Microbiology and Immunology, and Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, California, USA.
Penney M Gilbert1] Baxter Laboratory for Stem Cell Biology, Department of Microbiology and Immunology, and Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, California, USA. [2] Institute of Biomaterials and Biomedical Engineering and Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, Ontario, Canada.
Ermelinda PorpigliaBaxter Laboratory for Stem Cell Biology, Department of Microbiology and Immunology, and Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, California, USA.
Foteini MourkiotiBaxter Laboratory for Stem Cell Biology, Department of Microbiology and Immunology, and Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, California, USA.
Steven P LeeBaxter Laboratory for Stem Cell Biology, Department of Microbiology and Immunology, and Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, California, USA.
Stephane Y CorbelBaxter Laboratory for Stem Cell Biology, Department of Microbiology and Immunology, and Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, California, USA.
Michael E LlewellynDepartment of Bioengineering, Stanford University School of Medicine, Stanford, California, USA.
Scott L Delp1] Department of Bioengineering, Stanford University School of Medicine, Stanford, California, USA. [2] Department of Mechanical Engineering, Stanford University School of Medicine, Stanford, California, USA.
Helen M BlauBaxter Laboratory for Stem Cell Biology, Department of Microbiology and Immunology, and Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, California, USA.
Stanford University · USBaxter (United States) · US

Funding

Progenitor Cell Biology Consortium Administrative Coordinating CenterU01HL099997 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI TERRIN, MICHAEL L · 2009 to 2015
$29.9M
Basic and Translational Research iPSC-based hematologic and vascular therapiesU01HL100397 · NHLBI · STANFORD UNIVERSITY · PI COOKE, JOHN P · 2009 to 2015
$7.4M
TUMOR BIOLOGYT32CA009151 · NCI · STANFORD UNIVERSITY · PI CLEARY, MICHAEL L · 1985 to 2014
$5.5M
Stem Cells for Brain and BrawnR01AG020961 · NIA · STANFORD UNIVERSITY · PI BLAU, HELEN M · 2002 to 2019
$5.0M
Stanford Molecular Imaging Scholars - SMISR25CA118681 · NCI · STANFORD UNIVERSITY · PI LEVIN, CRAIG S · 2006 to 2015
$5.0M
ACTIVATORS OF MUSCLE GENESR01AG009521 · NIA · STANFORD UNIVERSITY · PI BLAU, HELEN M · 1990 to 2014
$4.7M
Telomere extension using nucleoside-modified mRNA and exosomes as a novel therapeR01AR063963 · NIAMS · STANFORD UNIVERSITY · PI BLAU, HELEN M · 2012 to 2016
$4.3M
Regulation of Hematopoietic Stem Cell Fate in Bioengineered NichesR01HL096113 · NHLBI · STANFORD UNIVERSITY · PI BLAU, HELEN M · 2009 to 2013
$2.7M
Safe, Rapid Telomere Extension to Prevent and Treat HypertensionR21AG044815 · NIA · STANFORD UNIVERSITY · PI BLAU, HELEN M · 2013 to 2014
$434k
Ex vivo rejuvenation and expansion of muscle stem cells from aged miceK99AG042491 · NIA · STANFORD UNIVERSITY · PI COSGROVE, BENJAMIN DAVID · 2012 to 2013
$177k
Physical Regulation of Muscle Stem Cells in Bioengineered 3D ModelsK99AR061465 · NIAMS · STANFORD UNIVERSITY · PI GILBERT, PENNEY MARIE · 2011 to 2011
$86k
NCI NIH HHS R25 CA118681NCI NIH HHS R25CA118681NCI NIH HHS T32 CA009151NCI NIH HHS T32CA009151NHLBI NIH HHS R01 HL096113NHLBI NIH HHS R01HL096113NHLBI NIH HHS U01 HL099997NHLBI NIH HHS U01HL099997NHLBI NIH HHS U01 HL100397NHLBI NIH HHS U01HL100397NIAMS NIH HHS K99 AR061465NIAMS NIH HHS K99AR061465NIAMS NIH HHS R01 AR063963NIA NIH HHS K99 AG042491NIA NIH HHS K99AG042491NIA NIH HHS R01 AG009521NIA NIH HHS R01AG009521NIA NIH HHS R01 AG020961NIA NIH HHS R01AG020961NIA NIH HHS R21 AG044815
6 · The paper itself

Abstract

The elderly often suffer from progressive muscle weakness and regenerative failure. We demonstrate that muscle regeneration is impaired with aging owing in part to a cell-autonomous functional decline in skeletal muscle stem cells (MuSCs). Two-thirds of MuSCs from aged mice are intrinsically defective relative to MuSCs from young mice, with reduced capacity to repair myofibers and repopulate the stem cell reservoir in vivo following transplantation. This deficiency is correlated with a higher incidence of cells that express senescence markers and is due to elevated activity of the p38α and p38β mitogen-activated kinase pathway. We show that these limitations cannot be overcome by transplantation into the microenvironment of young recipient muscles. In contrast, subjecting the MuSC population from aged mice to transient inhibition of p38α and p38β in conjunction with culture on soft hydrogel substrates rapidly expands the residual functional MuSC population from aged mice, rejuvenating its potential for regeneration and serial transplantation as well as strengthening of damaged muscles of aged mice. These findings reveal a synergy between biophysical and biochemical cues that provides a paradigm for a localized autologous muscle stem cell therapy for the elderly.

Indexed as

AgingMuscle StrengthRegenerationRejuvenationAnimalsCell ProliferationCell TransplantationCellular SenescenceCyclin-Dependent Kinase Inhibitor p16Cyclin-Dependent Kinase Inhibitor p21FemaleGreen Fluorescent ProteinsHydrogelsMaleMiceMice, Inbred C57BLCdkn1a protein, mouseCdkn2a protein, mouseCyclin-Dependent Kinase Inhibitor p16Cyclin-Dependent Kinase Inhibitor p21Green Fluorescent ProteinsHydrogelsMitogen-Activated Protein Kinase 11Mitogen-Activated Protein Kinase 14Phosphoproteins

Identifiers

PMID24531378
PMCPMC3949152
OpenAlexW2138514622

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.